ArticleClinical and translational medicine2021

Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial.

Raquel Laza-Briviesca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.